Cargando…
Pure Ductal Carcinoma In Situ of the Breast: Analysis of 270 Consecutive Patients Treated in a 9-Year Period
SIMPLE SUMMARY: Ductal carcinoma in situ (DCIS) accounts for 20 to 25% of all breast cancers and its incidence of progression to invasive ductal carcinoma is at least 13 to 50%. The aim of our retrospective observational analysis is to review the issues of this histological type of cancer. We confir...
Autores principales: | Chiappa, Corrado, Bonetti, Alice, Jaber, Giulio Jad, De Berardinis, Valentina, Bianchi, Veronica, Rovera, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865419/ https://www.ncbi.nlm.nih.gov/pubmed/33498737 http://dx.doi.org/10.3390/cancers13030431 |
Ejemplares similares
-
Machine Learning techniques in breast cancer prognosis prediction: A primary evaluation
por: Boeri, Carlo, et al.
Publicado: (2020) -
Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
por: Kim, Shinn Young, et al.
Publicado: (2015) -
Grade of recurrent in situ and invasive carcinoma following treatment of pure ductal carcinoma in situ of the breast
por: Millis, R R, et al.
Publicado: (2004) -
Wound healing and postsurgical complications in breast cancer surgery: a comparison between PEAK PlasmaBlade and conventional electrosurgery – a preliminary report of a case series
por: Chiappa, Corrado, et al.
Publicado: (2018) -
Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast
por: Zavagno, Giorgio, et al.
Publicado: (2005)